Donepezil (Aricept)

What it treats

Donepezil is approved by the U.S. Food and Drug Administration for mild, moderate, and severe Alzheimer's disease dementia. It's also used off-label for cognitive symptoms in other dementias (Lewy body dementia, Parkinson's disease dementia, vascular dementia), though evidence varies by condition.

It's a symptomatic treatment. It doesn't change the underlying disease. The goal is to slow the slope of decline and, in some people, get back a modest amount of function or attention for a while.

How it works

In Alzheimer's disease, the brain loses cells that make acetylcholine, a chemical messenger involved in memory and attention. Donepezil blocks the enzyme (acetylcholinesterase) that breaks acetylcholine down, which raises the amount available at nerve endings.

That extra acetylcholine can help the remaining circuits work a little better. Over time the underlying cell loss continues, so the drug's ceiling comes down as the disease progresses. This is why the effect is called symptomatic: the machinery is failing, and donepezil is running the remaining parts a bit harder.

Receptor mechanism (detail)

Donepezil is a selective, reversible inhibitor of acetylcholinesterase (AChE) in the central nervous system. Blocking this enzyme raises synaptic acetylcholine, which acts at both muscarinic and nicotinic receptors throughout the brain and body. The peripheral cholinergic effects (gut, heart, bladder) are where most of the side effects come from.

Potency and typical dosing pattern

Ranges are typical framework only, not a prescription for any individual.

The standard start is 5 mg at bedtime for at least 4 weeks, then a step up to 10 mg at bedtime. For moderate to severe Alzheimer's, a 23 mg tablet is available. The 23 mg dose offers a small added benefit on some measures over 10 mg, with meaningfully more nausea, vomiting, and weight loss. Most clinicians hold at 10 mg unless there's a specific reason to push higher.

The bedtime dose is traditional, but if vivid dreams or nightmares become a problem, moving it to the morning is a common fix.

Safety monitoring

• Heart rate and rhythm. Donepezil can slow the heart. Baseline pulse check and a low threshold for an ECG in anyone with a history of arrhythmia, syncope, or existing bradycardia.
• Weight. Track it. Steady weight loss over months is a real problem in older adults on cholinesterase inhibitors.
• GI symptoms. Nausea, diarrhea, and vomiting are common early. Persistent GI upset that limits eating means the drug isn't tolerated.
• Falls and syncope. New falls or fainting spells need a look at whether the drug or a combination with a beta blocker is contributing.
• Sleep. Vivid dreams and nightmares are common. Ask about them.
• Urinary symptoms. Some people develop new incontinence or urgency.

What to expect

The honest framing: don't expect a dramatic before-and-after. The effect emerges gradually and shows up as a slowing of decline rather than an obvious improvement. Over the first 3 to 6 months, families sometimes notice better attention, engagement, or word-finding compared to what they were expecting. Formal cognitive scores typically drift down more slowly than they would without treatment.

Side effects, if they come, show up early. Nausea and loose stools are the usual complaints in the first few weeks, and they tend to settle. Vivid dreams often appear once the person has been on it a while and can be a reason to switch the timing to morning.

Benefit doesn't last forever. As the disease progresses, the underlying cholinergic circuits keep dropping out, and the drug has less to work with.

Common side effects

Most people who get side effects get GI ones first.

• Nausea.
• Diarrhea.
• Muscle cramps.
• Loss of appetite and weight loss.
• Vivid dreams or nightmares.
• Fatigue.
• Dizziness.
• Insomnia.

Many of these ease over the first few weeks. Slow titration (waiting the full 4 weeks before going up) is the main way to reduce them.

Serious side effects and warnings

Serious problems are uncommon but worth knowing.

• Bradycardia and syncope. Donepezil slows the heart. This becomes a real problem in people on beta blockers, non-dihydropyridine calcium channel blockers (verapamil, diltiazem), or digoxin, and in people with pre-existing conduction disease. Fainting spells are a reason to stop and reassess.
• GI bleeding. Cholinergic drugs increase stomach acid. Risk is higher in people on NSAIDs or with a history of ulcer.
• Weight loss. Meaningful and progressive weight loss can happen and is important in a population already at risk of frailty.
• Seizures. Rare, but reported.
• Urinary obstruction. Can worsen symptoms in people with existing bladder outlet issues.
• Neuromuscular blockade during anesthesia. Surgical teams should know the patient is on donepezil.

Sexual and relational effects

Sexual side effects with donepezil aren't a common complaint, and libido changes are more often driven by the dementia itself than by the drug. The real relational impact is different. Care partners often ask whether the drug will make the person "themselves" again. The honest answer is usually no, but modest gains in engagement, humor, or participation in daily life do happen for some people, and those small wins matter to families.

Weight, appetite, and sleep

Weight loss is one of the more clinically important side effects. Appetite often dips, especially in the first few months, and older adults have less reserve to lose. Track weight every visit.

Sleep can go either way. Some people get insomnia; others get vivid dreams that wake them or the bed partner. Moving the dose from bedtime to morning is the standard workaround.

Starting and dosing basics

This section is general background, not a dosing instruction for any individual. The right dose is a decision for a prescriber.

Donepezil comes as tablets (5, 10, 23 mg) and an orally disintegrating tablet, which is helpful in people who have trouble swallowing. The usual sequence is 5 mg at bedtime for at least 4 weeks, then 10 mg at bedtime. The 23 mg tablet is reserved for moderate to severe disease when the family and prescriber agree the small added benefit is worth the higher side-effect rate.

Taking it with food doesn't change absorption much and can reduce nausea.

Missed doses and interactions

If a dose is missed, take it when remembered unless it's close to the next scheduled dose. Don't double up.

The interactions that matter clinically are:

• Beta blockers and other rate-slowing drugs. Additive bradycardia.
• NSAIDs. Increased GI bleeding risk.
• Anticholinergics. Drugs like diphenhydramine, oxybutynin, and older tricyclics pharmacologically oppose donepezil and can worsen cognition. This is a common and often missed problem in older adults.
• Strong CYP3A4 or CYP2D6 inhibitors and inducers can shift donepezil levels. Give every prescriber a full medication list.
• Succinylcholine. Prolonged neuromuscular blockade during anesthesia.

Stopping and tapering

Donepezil doesn't cause a classic physical withdrawal, but stopping abruptly can be followed by a step-down in cognition or function within a few weeks. Sometimes that drop doesn't recover when the drug is restarted. If the plan is to stop, tapering over several weeks and watching for a change in function is safer than a hard stop.

Reasons to stop include intolerable side effects, advanced disease where the drug is no longer providing meaningful benefit, and end-of-life care. This is a decision for the family, patient (where possible), and prescriber together.

Pregnancy and breastfeeding

This isn't a common issue given the patient population. Donepezil is not used in pregnancy or breastfeeding in ordinary practice. Anyone in an unusual clinical situation involving reproductive planning should discuss it with a specialist.

Cost and generic availability

Donepezil has been generic for many years and is inexpensive. The 5 and 10 mg tablets and the orally disintegrating tablet are widely covered. The 23 mg tablet is more expensive and often not preferred by insurers unless there's a clear reason.

Common questions

Will donepezil bring my parent back? No. It doesn't reverse the disease, and it doesn't restore lost function. What it can do is slow the slope of decline for a stretch of months and, in some people, give a modest, temporary bump in attention and engagement.

How long should we stay on it? As long as the family and prescriber agree it's helping and being tolerated. That often means years in mild to moderate disease. At some point in severe disease the balance shifts and stopping becomes reasonable.

Why bedtime? That's how the trials were done and how the label is written. If vivid dreams become a problem, switching to morning is a standard fix and doesn't change how well it works.

Is the 23 mg dose worth it? For most people, no. The added benefit is small and the added side effects (weight loss, GI upset) aren't. Some families and prescribers try it in moderate to severe disease.

What if the person also has heart disease? Tell the prescriber. A baseline ECG and a careful look at other rate-slowing drugs is standard.

Questions to ask your prescriber

• What are we hoping to see, and how will we know it's working?
• How will we track weight and heart rate?
• Are any of the current medications a problem to combine with donepezil?
• What would tell us it's time to move up to 10 mg, or time to stop?
• If side effects come up, what's the plan?

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes, and current as of June 8, 2026.

• U.S. Food and Drug Administration. Donepezil (Aricept) prescribing information.
• DailyMed, U.S. National Library of Medicine. Donepezil label.
• MedlinePlus, U.S. National Library of Medicine. Donepezil.
• National Institute of Mental Health. Mental health medications.
• American Academy of Neurology. Practice guideline update on pharmacologic treatment of dementia.
• American Psychiatric Association. Practice guideline on the use of antipsychotics and cognitive enhancers in dementia.